STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for HPV throat cancer
Disease control CompletedThis study tested a treatment for HPV-related throat cancer using higher-frequency radiation plus the chemotherapy drug docetaxel. The goal was to improve tumor control and survival. 81 patients participated in this phase II trial at the Mayo Clinic.
Matched conditions: STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Could less radiation be enough for certain throat cancers?
Disease control CompletedThis study looked at whether a lower dose of radiation therapy, with or without the chemotherapy drug cisplatin, is safe and effective for people with advanced oropharyngeal (throat) cancer that is linked to HPV (p16 positive) and occurs in non-smokers. About 316 participants wer…
Matched conditions: STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 11, 2026 20:52 UTC